SAN FRANCISCO, April 2, 2018 /PRNewswire/ --
The global therapeutic respiratory devices market is anticipated
to reach USD 18.0 billion
by 2025, according to a new report by Grand View Research, Inc. Growing geriatric population base, rising prevalence of respiratory diseases, and rapid technological advancements are the key factors
that are driving the market growth.
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
The therapeutic respiratory devices market growth is anticipated to increase due to rapid technological advancements in the market.Now-a-days, the respiratory monitoring devices utilize software applications for the collection and analysis of data from ventilators equipped across the health system. The tools in the software application allow improvised patient monitoring by the measurement of parameters such as process and clinical variation in the ventilator therapy.
Furthermore, waveform capnography is a useful technical advancement in monitoring the carbon dioxide levels. The launch of new products such as automated and stand-alone pressure controller for mechanical ventilators boost the growth of therapeutic respiratory devices market. These pressure controllers enable reduction in the risk of tracheal injuries and Ventilator Associated Pneumonia (VAP). For instance, in May 2015, Fischer and Paykel launched its new product AIRVO Nasal High Flow System, which provides comfort and stability for patients. It has soft contoured cheek pads and prongs, uninterrupted power supply transport, and tube technology with two way spiral design. The company also offers humidifier with integrated flow generator, which delivers high flows of air mixture to spontaneously breathing patient. Such factors are bolstering the growth of the market.
Browse full research report with TOC on
"Therapeutic Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Oxygen Concentrators, Positive Airway Pressure Devices) And Segment Forecasts, 2018 - 2025" at:
Further Key Findings From the Report Suggest:
- Positive airway pressure devices accounted for the largest share in 2016 owing to technological innovations resulting in increased portability and shelf life.
- HEPA filter technology accounted for the largest share in 2016, due to the prevalence of respiratory diseases & their transmission coupled with technological advancements in this segment.
- Humidifiers is anticipated to be the fastest growing segment in the forecast period owing to the rising demand for humidifiers in hospitals, schools, home, & healthcare entities, and increased prevalence of airborne infections such as tuberculosis.
- North America therapeutic respiratory devices market is the largest market and is expected to maintain its position over the forecast period owing to the presence of large geriatric population base and rising prevalence of chronic respiratory diseases.
- Major players of the market include, Carefusion Corporation, GE Heathcare, AirSep Corporation, Philips Healthcare, Smiths Medical and Covidien PLC.
Browse related reports by Grand View Research:
- Hospital Microbiology Testing Market
- The Global hospital microbiology testing market is expected to witness lucrative growth over the forecast period.
- Neuroprosthetics Market - The global neuroprosthetics market was valued at USD 4.2 billion in 2015.
- Steam Autoclaves Market - The global steam autoclaves market was valued at USD 1,452.9 million in 2014 and is expected to grow at a CAGR of 8.9% over the forecast period.
- Smart Syringes Market - The global smart syringes market was valued at USD 4.75 billion in 2015.
Grand View Research has segmented the global therapeutic respiratory devices market on the basis of product, technology, filters, and region:
- Therapeutic Respiratory Devices Product Type Outlook (Revenue, USD Million, 2014 - 2025)
- Compressor-based nebulizers
- Piston based hand held nebulizer
- Ultrasonic Nebulizer
- Heated humidifiers
- Passover humidifiers
- Integrated humidifiers
- Built-In humidifiers
- Stand-alone humidifiers
- Oxygen Concentrators
- Fixed oxygen concentrators
- Portable oxygen concentrators
- Positive Airway Pressure Devices
- Continuous positive airway pressure devices
- Auto-titrating positive airway pressure devices
- Bi-level positive airway pressure devices
- Adult ventilators
- Neonatal ventilators
- Gas Analyzers
- Therapeutic Respiratory Devices Technology Outlook (Revenue, USD Million, 2014 - 2025)
- Electrostatic Filtration
- HEPA filter technology
- Hollow fiber filtration
- Microsphere separation
- Therapeutic Respiratory Devices Filters Outlook (Revenue, USD Million, 2014 - 2025)
- Nebulizer filters
- Inlet filter
- Replacement filter
- Cabinet filter
- Humidifier filters
- Wick filters
- Permanent cleanable filters
- Mineral absorption pads
- Demineralization cartridges
- Positive airway pressure devices filter
- Ultra fine foam inlet filters
- Polyester non-woven fiber filters
- Acrylic & Polypropylene fiber filters
- Oxygen concentrator filters
- HEPA filter
- Cabinet filter
- Pre-Inlet filter
- Inlet filter
- Micro disk filter
- Felt intake filter
- Bacterial filter
- Hollow-membrane filter
- Ventilator filters
- Mechanical filters
- HEPA Filters
- ULPA Filters
- Activated carbon filters
- Electrostatic filters
- Tribocharged filters
- Fibrillated filters
- Therapeutic Respiratory Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- Asia Pacific
- Latin America
Read Our Blog By Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519
SOURCE Grand View Research, Inc.